The experimental results of AMPC were published in the journal Medicine in 2023 (https://pubmed.ncbi.nlm.nih.gov/36701726/ ; DOI: 10.1097/MD.0000000000032746)
Using ASCT’s patented technology, the white blood cells in human blood are cultured to increase the expression of stem cell genes OCT4, NANOG, SOX2 and self-renewal gene TERT and cell plasticity.

AMPC applied for patents in the United States, Australia and Europe, and obtained a U.S. patent in 2022